Evidence map›Paper›PMID 26502073›Full record

ArticleJAMA pediatrics2015

Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants.

Jessica E Ericson, Victor O Popoola, P Brian Smith, Daniel K Benjamin, Vance G Fowler, Daniel K Benjamin, Reese H Clark, Aaron M Milstone

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in JAMA pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Impact of methicillin-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  15. Article
  16. Article
  17. A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  18. Microbiome dysbiosis: a modifiable state and target to prevent Staphylococcus aureus infections and other diseases in neonates.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  19. Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Review
  20. Healthcare worker perceptions surroundingInfection control and hospital epidemiology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Jessica E EricsonDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina2Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina3currently with the Department of Pediatrics, Penn State College of Medicine.
Victor O PopoolaDivision of Infectious Diseases, Department of Pediatrics, The Johns Hopkins University, Baltimore, Maryland.
P Brian SmithDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina2Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
Daniel K BenjaminDepartment of Economics, Clemson University, Clemson, South Carolina.
Vance G FowlerDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina6Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Daniel K BenjaminDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina2Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
Reese H ClarkPediatrix Medical Group, Sunrise, Florida.
Aaron M MilstoneDivision of Infectious Diseases, Department of Pediatrics, The Johns Hopkins University, Baltimore, Maryland.
Clinical Research Institute · USClemson University · USDuke University · USJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
Duke CTSA (Composite)UL1TR001117 · NCATS · DUKE UNIVERSITY · PI BOULWARE, LEIGH E, LI, JENNIFER S · 2013 to 2017
$41.3M
Increasing the Quality and Efficiency of Clinical Trials (R18)R18FD005292 · FDA · DUKE UNIVERSITY · PI LI, JENNIFER S · 2014 to 2019
$26.8M
Host Susceptibility to S. aureusR01AI068804 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G. · 2007 to 2016
$6.9M
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemiaR01HD081044 · NICHD · DUKE UNIVERSITY · PI FISHER, BRIAN T, STEINBACH, WILLIAM J · 2014 to 2018
$3.2M
Decreasing Neonatal Staphylococcus aureus Disease Through Parental InterventionR01HS022872 · AHRQ · JOHNS HOPKINS UNIVERSITY · PI MILSTONE, AARON M · 2014 to 2017
$1.9M
Mentoring Patient Oriented Research in Antibiotic-Resistant BacteriaK24AI093969 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G. · 2011 to 2020
$1.6M
Mentorship of early-career pediatricians in quantitiative methods and therapeuticK24HD058735 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K. · 2009 to 2018
$1.5M
Institutional Training Grant in Pediatric Infectious DiseaseT32HD060558 · NICHD · DUKE UNIVERSITY · PI CUNNINGHAM, COLEEN K. · 2011 to 2015
$1.0M
Impact of decolonization on MRSA transmission in neonatesR03AI117169 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MILSTONE, AARON M · 2015 to 2016
$175k
AHRQ HHS R01 HS022872AHRQ HHS R01HS022872FDA HHS R18 FD005292NCATS NIH HHS UL1 TR001117NCATS NIH HHS UL1TR001117NIAID NIH HHS HHSN272201500006CNIAID NIH HHS K24 AI093969NIAID NIH HHS K24-AI093969NIAID NIH HHS R01 AI068804NIAID NIH HHS R01-AI068804NIAID NIH HHS R03 AI117169NIAID NIH HHS R03AI117169NIAID NIH HHS UM1 AI104681NIAID NIH HHS UM1AI104681NICHD NIH HHS 1R01-HD081044-01NICHD NIH HHS 2K24HD058735-06NICHD NIH HHS 5T32HD060558NICHD NIH HHS HHSN275201000003CNICHD NIH HHS HHSN275201000003INICHD NIH HHS K24 HD058735NICHD NIH HHS R01 HD081044NICHD NIH HHS T32 HD060558
6 · The paper itself

Abstract

importanceStaphylococcus aureus is a frequent cause of infection in hospitalized infants. These infections are associated with increased mortality and morbidity and longer hospital stays, but data on the burden of S aureus disease in hospitalized infants are limited.

objectivesTo compare demographics and mortality of infants with invasive methicillin-resistant S aureus (MRSA) and methicillin-susceptible S aureus (MSSA), to determine the annual proportion of S aureus infections that were MRSA, and to contrast the risk of death after an invasive MRSA infection with the risk after an invasive MSSA infection. DESIGN, SETTING, AND

participantsMulticenter retrospective study of a large, nationally representative cohort at 348 neonatal intensive care units managed by the Pediatrix Medical Group. Participants were 3888 infants with an invasive S aureus infection who were discharged from calendar year 1997 through calendar year 2012. EXPOSURE: Invasive S aureus infection. MAIN OUTCOMES AND MEASURES: The incidence of invasive S aureus infections, as well as infant characteristics and mortality after MRSA or MSSA infection.

resultsThe 3888 infants had 3978 invasive S aureus infections (2868 MSSA and 1110 MRSA). The incidence of invasive S aureus infection was 44.8 infections per 10,000 infants. The yearly proportion of invasive infections caused by MRSA increased from calendar year 1997 through calendar year 2006 and has moderately decreased since then. Infants with invasive MRSA or MSSA infections had similar gestational ages and birth weights. Invasive MRSA infections occurred more often at a younger postnatal age. For infants with available mortality data, more infants with invasive MSSA infections (n = 237) died before hospital discharge than infants with invasive MRSA infections (n = 110). The proportions of infants who died after invasive MSSA and MRSA infections were similar at 237 of 2474 (9.6%) and 110 of 926 (11.9%), respectively (P = .05). The adjusted risk of death before hospital discharge was similar after invasive MSSA and MRSA infections (risk ratio, 1.19; 95% CI, 0.96-1.49). The risks of death at 7 and 30 days after invasive infection were similar between infants with invasive MSSA infection and infants with invasive MRSA infection. CONCLUSIONS AND RELEVANCE: Infant mortality after invasive MRSA and MSSA infections is similar, but MSSA causes more infections and more deaths in infants than MRSA. Measures to prevent S aureus infection should include MSSA in addition to MRSA.

Indexed as

Cost of IllnessFemaleHospitalizationHumansIncidenceInfantInfant MortalityInfant, NewbornIntensive Care Units, NeonatalMaleMethicillin-Resistant Staphylococcus aureusRetrospective StudiesRisk FactorsStaphylococcal InfectionsStaphylococcus aureus

Identifiers

PMID26502073
PMCPMC4694042
OpenAlexW2119741711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.